Symetryx Corp's Form 4 filing
NeuBase Therapeutics, Inc. (NBSE) · filed Sep 7, 2023
- Accession no.
- 0001991925-23-000002
- Filed
- Sep 7, 2023
- Trade date
- Sep 1, 2023
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $59.9K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Symetryx CorpCIK 0001991925 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock, Par Value $0.0001 per Share | PPurchaseAcquired | +61,076 | $0.98 | +$59,854.48 | 680,081 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.